Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to most subscription-based ‘Open Select’ Taylor & Francis journals, fully OA journals, F1000 and Routledge Open journals. 35 subscription-based journals are excluded from the agreement – see list below for details
Agreement applies to funded and unfunded papers
Corresponding author must be affiliated with The University of Manchester
Agreement covers full cost of Article Processing Charge (APC)
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences
During the submission process, corresponding authors must use their university email address in order to be identified as eligible for the deal.
Find information about our other active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Subscription-based journals excluded from agreement:
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
The University does not have an Open Access (OA) agreement with MDPI.
We have a prepayment account we use to pay Article Processing Charges (APC’s), which provides us with a 10% discount.
For us to pay an MDPI APC, authors need to request OA funding using our Open Access enquiry form.
As a fully OA publisher, MDPI journals are eligible for the use of our OA budgets. You can check your eligibility for these budgets in our Open Access funds available for University of Manchester researchers article.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Drug Delivery serves the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to most subscription-based ‘Open Select’ Taylor & Francis journals, fully OA journals, F1000 and Routledge Open journals. 35 subscription-based journals are excluded from the agreement – see list below for details
Agreement applies to funded and unfunded papers
Corresponding author must be affiliated with The University of Manchester
Agreement covers full cost of Article Processing Charge (APC)
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences
During the submission process, corresponding authors must use their university email address in order to be identified as eligible for the deal.
Find information about our other active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
Subscription-based journals excluded from agreement:
Drug Delivery Letters publishes letters, original research papers, full-length/mini reviews and guest edited issues in all important aspects of drug delivery, gene delivery, and drug targeting.
The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The journal also focuses on all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines and gene delivery, etc. The manuscript submission process is fully electronic to ensure rapid publication of research results.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions. Research focused on the following areas of translational drug delivery research will be considered for publication in the journal. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions: Preclinical and clinical data related to drug delivery systems: Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes Short-term and long-term biocompatibility of drug delivery systems, host response: Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering: Image-guided drug therapy, Nanomedicine: Devices for drug delivery and drug/device combination products. In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Review and original research articles can be published immediately Open Access at no cost to the author
Agreement applies to Springer, Palgrave and Nature subscription journals (excluding Nature Reviews). See list of eligible journals on the Springer Nature website
Agreement applies to both funded and unfunded papers
Corresponding author must be affiliated with The University of Manchester
If you are publishing in a fully Open Access Springer, Palgrave, BMC or Nature journal, please request funding from the Library.
Agreement covers full cost of Article Processing Charge (APC)
This publisher has a wide-ranging portfolio of journals covering most disciplines supported at The University of Manchester, from the Humanities to the Sciences.
During the submission process, state that you are affiliated with the University of Manchester and use your university email address.
Find information about all of our active Open Access agreements.
Need any help? You can find more articles about other Open Access-related topics or get in touch with the team.
